首页> 外文期刊>Radiation oncology >Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications
【24h】

Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications

机译:局部晚期直肠癌(LARC)中的调强放射疗法(IMRT)与3D适形放射疗法(3DCRT):剂量学比较和临床意义

获取原文
           

摘要

Purpose To compare target dose distribution, comformality, normal tissue avoidance, and irradiated body volume (IBV) in 3DCRT using classic anatomical landmarks (c3DCRT), 3DCRT fitting the PTV (f3DCRT), and intensity-modulated radiation therapy (IMRT) in patients with locally advanced rectal cancer (LARC). Materials and methods Fifteen patients with LARC underwent c3DCRT, f3DCRT, and IMRT planning. Target definition followed the recommendations of the ICRU reports No. 50 and 62. OAR (SB and bladder) constraints were D5 ≤ 50 Gy and Dmax < 55 Gy. PTV dose prescription was defined as PTV95 ≥ 45 Gy and PTVmin ≥ 35 Gy. Target coverage was evaluated with the D95, Dmin, and Dmax. Target dose distribution and comformality was evaluated with the homogeneity indices (HI) and Conformity Index (CI). Normal tissue avoidance of OAR was evaluated with the D5 and V40. IBV at 5 Gy (V5), 10 Gy (V10), and 20 Gy (V20) were calculated. Results The mean GTV95, CTV95, and PTV95 doses were significantly lower for IMRT plans. Target dose distribution was more inhomogeneous after IMRT planning and 3DCRTplans had significantly lower CI. The V40 and D5 values for OAR were significantly reduced in the IMRT plans .V5 was greater for IMRT than for f3DCRT planning (p < 0.05) and V20 was smaller for IMRT plans(p < 0.05). Conclusions IMRT planning improves target conformity and decreases irradiation of the OAR at the expense of increased target heterogeneity. IMRT planning increases the IBV at 5 Gy or less but decreases the IBV at 20 Gy or more.
机译:目的为了比较3DCRT患者的目标剂量分布,适形性,避免正常组织以及受照人体体积(IBV),使用经典解剖学界标(c3DCRT),适合PTV的3DCRT(f3DCRT)和强度调制放射治疗(IMRT)局部晚期直肠癌(LARC)。材料和方法15例LARC患者接受了c3DCRT,f3DCRT和IMRT计划。目标定义遵循ICRU报告第50和62号的建议。OAR(SB和膀胱)的限制条件是D5≤50 Gy和Dmax <55 Gy。 PTV剂量处方定义为PTV95≥45 Gy和PTVmin≥35 Gy。使用D95,Dmin和Dmax评估目标覆盖率。使用均匀性指数(HI)和合格指数(CI)评估目标剂量分布和适形性。用D5和V40评估OAR正常组织避免情况。计算了5 Gy(V5),10 Gy(V10)和20 Gy(V20)的IBV。结果IMRT计划的GTV95,CTV95和PTV95的平均剂量显着降低。 IMRT计划和3DCRT计划的CI显着降低后,目标剂量分布更加不均匀。 IMRT计划中OAR的V40和D5值显着降低。IMRT计划中的V5大于f3DCRT计划中的V5(p <0.05),IMRT计划中的V20较小(p <0.05)。结论IMRT计划提高了目标的一致性,并减少了OAR的辐照,但代价是增加了目标异质性。 IMRT计划将IBV增加到5 Gy或更小,但是将IBV减小到20 Gy或更多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号